Clinical Trials Browser

Phase 1/2 × Interventional × Lapatinib × Clear all

NCT01589861 2026-04-21

PIKHER2

Phase 1/2 Terminated

Breast Neoplasms

NCT02230553 2025-07-08

M14LTK

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms

NCT00455039 2023-08-14

INST 0514C- Biologic Correlative Study: Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients

Phase 1/2 Withdrawn

Breast Neoplasms

NCT01138384 2023-08-04

Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer

Phase 1/2 Completed

Breast Neoplasms

NCT00952692 2021-12-20

Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer

Phase 1/2 Completed

12 enrolled 9 charts

Breast Neoplasms

NCT01118975 2019-11-13

GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers

Phase 1/2 Terminated

12 enrolled 6 charts

Breast Neoplasms, Neoplasm Metastasis

NCT01783756 2019-11-12

Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis

Phase 1/2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00912275 2019-05-06

Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast Cancer

Phase 1/2 Completed

Breast Neoplasms

NCT00953576 2018-09-04

KHLAD

Phase 1/2 Terminated

11 enrolled 9 charts

Prostatic Neoplasms

NCT00498953 2018-07-09

Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx

Phase 1/2 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT02422199 2018-07-09

A Study of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+Metastatic Breast Cancer Who Have Prior Received Anthracyclin, Taxane or Trastuzumab

Phase 1/2 Unknown

HER2 Positive Metastatic Breast Cancer

NCT01172223 2016-11-02

LAPADO

Phase 1/2 Completed

Breast Neoplasms

NCT00450892 2016-07-07

Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer

Phase 1/2 Completed

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT01495884 2015-10-26

The Myocet/Lapatinib Study. ICORG 10-03, V5

Phase 1/2 Terminated

Her2 Positive Metastatic Breast Cancer

NCT00095940 2014-05-23

Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors

Phase 1/2 Completed

52 enrolled 17 charts

Familial ependymoma, Astrocytoma, Glioblastoma, Medulloblastoma, Oligodendroglioma

NCT00099060 2014-01-27

Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme

Phase 1/2 Completed

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT01658358 2013-02-27

ErbB2 Positive Metastatic Breast Cancer

Phase 1/2 Terminated

Breast Neoplasms

NCT01044485 2012-09-25

LapDoc

Phase 1/2 Completed

Breast Neoplasms

NCT00316407 2011-02-18

Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients

Phase 1/2 Completed

BreastGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Ovarian Neoplasms